Differences between the European and Eurasian Good Pharmacovigilance Practices

Good pharmacovigilance practices (GVP) of the Eurasian Economic Union (EAEU) were prepared based on the GVP of the European Medicines Agency that have been in force in the European Union (EU) since 2012. The EAEU GVP have been in force in the Russian Federation and the other EAEU member states since...

ver descrição completa

Detalhes bibliográficos
Principais autores: A. V. Matveev, A. E. Krasheninnikov, E. A. Matveeva, B. K. Romanov
Formato: Artigo
Idioma:Russian
Publicado em: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2021-07-01
coleção:Безопасность и риск фармакотерапии
Assuntos:
Acesso em linha:https://www.risksafety.ru/jour/article/view/220